Humana Inc (HUM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,910,000 | 4,694,000 | 15,148,000 | 16,214,000 | 13,735,000 |
| Marketable Securities | 16,697,000 | 16,626,000 | 15,145,000 | 15,251,000 | 14,932,000 |
| Receivables | 3,925,000 | 2,035,000 | 1,824,000 | 1,429,000 | 3,107,000 |
| Other current assets | 6,264,000 | 6,631,000 | 6,136,000 | 5,865,000 | 5,758,000 |
| TOTAL | $32,796,000 | $29,986,000 | $38,253,000 | $38,759,000 | $37,532,000 |
| Non-Current Assets | |||||
| PPE Net | 2,979,000 | 3,030,000 | 3,342,000 | 3,309,000 | 3,234,000 |
| Investments And Advances | 1,110,000 | 1,122,000 | 1,132,000 | 1,122,000 | 1,110,000 |
| Intangibles | 9,563,000 | 9,550,000 | 9,540,000 | 9,539,000 | 9,320,000 |
| Other Non-Current Assets | 3,643,000 | 3,377,000 | 3,638,000 | 3,726,000 | 3,580,000 |
| TOTAL | $17,295,000 | $17,079,000 | $17,652,000 | $17,696,000 | $17,244,000 |
| Total Assets | $50,091,000 | $47,065,000 | $55,905,000 | $56,455,000 | $54,776,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 822,000 | 1,443,000 | 2,245,000 | 2,022,000 | 1,867,000 |
| Accounts payable and accrued liabilities | 18,233,000 | 16,810,000 | 17,796,000 | 18,422,000 | 17,449,000 |
| TOTAL | $19,689,000 | $18,872,000 | $27,823,000 | $28,279,000 | $26,942,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,390,000 | 10,213,000 | 9,483,000 | 9,722,000 | 9,743,000 |
| Deferred Revenues | 301,000 | 266,000 | 7,536,000 | 7,378,000 | 7,220,000 |
| Other Non-Current Liabilities | 1,828,000 | 1,661,000 | 1,597,000 | 1,566,000 | 1,458,000 |
| TOTAL | $14,216,000 | $11,875,000 | $11,078,000 | $11,285,000 | $11,200,000 |
| Total Liabilities | $33,905,000 | $30,747,000 | $38,901,000 | $39,564,000 | $38,142,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 120,501 | 120,653 | 123,111 | 123,907 | 124,945 |
| Common Shares | 33,000 | 33,000 | 33,000 | 33,000 | 33,000 |
| Retained earnings | 28,173,000 | 27,540,000 | 28,191,000 | 27,468,000 | 26,619,000 |
| Other shareholders' equity | -1,030,000 | -943,000 | -1,448,000 | -1,169,000 | -1,056,000 |
| TOTAL | $16,186,000 | $16,318,000 | $17,004,000 | $16,891,000 | $16,634,000 |
| Total Liabilities And Equity | $50,091,000 | $47,065,000 | $55,905,000 | $56,455,000 | $54,776,000 |